View in EDS

941TiP A phase I/IIa, open-label, dose-finding trial to evaluate safety, immunogenicity, and anti-tumour activity of VB10.16 in combination with pembrolizumab in patients with unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma (R/M HNSCC)

Saved in:
Bibliographic Details
Title: 941TiP A phase I/IIa, open-label, dose-finding trial to evaluate safety, immunogenicity, and anti-tumour activity of VB10.16 in combination with pembrolizumab in patients with unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma (R/M HNSCC)
Authors: Khalique, S.1 (AUTHOR), Oliva, M.2 (AUTHOR), Even, C.3 (AUTHOR), Dziadziuszko, R.4 (AUTHOR), Dietz, A.5 (AUTHOR), Italiano, A.6 (AUTHOR), Melichar, B.7 (AUTHOR), Martinez-Galan, J.8 (AUTHOR), Brydøy, M.9 (AUTHOR), Thouvenin, J.10 (AUTHOR), Rutkowski, T.11 (AUTHOR), Hitre, E.12 (AUTHOR), Guix Arnau, M.13 (AUTHOR), Lopez Criado, M.P.14 (AUTHOR), Jürgens, T.15 (AUTHOR), Bratland, Å.16 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS653-S653. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179692398
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 941TiP A phase I/IIa, open-label, dose-finding trial to evaluate safety, immunogenicity, and anti-tumour activity of VB10.16 in combination with pembrolizumab in patients with unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma (R/M HNSCC)
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Khalique%2C+S%2E%22">Khalique, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oliva%2C+M%2E%22">Oliva, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Even%2C+C%2E%22">Even, C.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dziadziuszko%2C+R%2E%22">Dziadziuszko, R.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dietz%2C+A%2E%22">Dietz, A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Italiano%2C+A%2E%22">Italiano, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Melichar%2C+B%2E%22">Melichar, B.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martinez-Galan%2C+J%2E%22">Martinez-Galan, J.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brydøy%2C+M%2E%22">Brydøy, M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thouvenin%2C+J%2E%22">Thouvenin, J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rutkowski%2C+T%2E%22">Rutkowski, T.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hitre%2C+E%2E%22">Hitre, E.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guix+Arnau%2C+M%2E%22">Guix Arnau, M.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lopez+Criado%2C+M%2EP%2E%22">Lopez Criado, M.P.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jürgens%2C+T%2E%22">Jürgens, T.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bratland%2C+Å%2E%22">Bratland, Å.</searchLink><relatesTo>16</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS653-S653. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179692398
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2024.08.1002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S653
    Titles:
      – TitleFull: 941TiP A phase I/IIa, open-label, dose-finding trial to evaluate safety, immunogenicity, and anti-tumour activity of VB10.16 in combination with pembrolizumab in patients with unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma (R/M HNSCC)
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Khalique, S.
      – PersonEntity:
          Name:
            NameFull: Oliva, M.
      – PersonEntity:
          Name:
            NameFull: Even, C.
      – PersonEntity:
          Name:
            NameFull: Dziadziuszko, R.
      – PersonEntity:
          Name:
            NameFull: Dietz, A.
      – PersonEntity:
          Name:
            NameFull: Italiano, A.
      – PersonEntity:
          Name:
            NameFull: Melichar, B.
      – PersonEntity:
          Name:
            NameFull: Martinez-Galan, J.
      – PersonEntity:
          Name:
            NameFull: Brydøy, M.
      – PersonEntity:
          Name:
            NameFull: Thouvenin, J.
      – PersonEntity:
          Name:
            NameFull: Rutkowski, T.
      – PersonEntity:
          Name:
            NameFull: Hitre, E.
      – PersonEntity:
          Name:
            NameFull: Guix Arnau, M.
      – PersonEntity:
          Name:
            NameFull: Lopez Criado, M.P.
      – PersonEntity:
          Name:
            NameFull: Jürgens, T.
      – PersonEntity:
          Name:
            NameFull: Bratland, Å.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2024 Supplement 2
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 35
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1